Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

23,956 signal articles · 377 in last 24h · 113,714 total before filter · latest 26m ago
377last 24h
2005last 7d
326● bullish (7d)
177● bearish (7d)
205publishers
AllMacro339Earnings1054M&A96Regulatory24Product18Analyst22
✕ clear all filtersticker: CSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Bloomberg75d agoneutral
Danish Pension Blacklists SpaceX Over ‘Catastrophic Governance’

(Bloomberg) -- A $25 billion Danish pension fund that earlier this year made headlines by ditching Treasuries as Donald Trump was threatening to seize Greenland now says it won’t touch SpaceX.Most Read from BloombergSingapore Hands Byju's Founder His First Ever Jail TermStrait of Hormuz Ship Transits Are Rising Thanks to Help From USCVS Returns Zepbound to Drug Plans After Lilly Slashes PriceApple to Overhaul iOS 27 Siri, AI Features: Here's a First PeekSpaceX Said to Cut IPO Value Goal to at Le

Bloomberg77d agoneutral
SpaceX Lowers IPO Valuation Target to at Least $1.8 Trillion

(Bloomberg) -- SpaceX is currently targeting a valuation of at least $1.8 trillion in its initial public offering, according to people familiar with the matter, as Elon Musk’s rocket and artificial intelligence company nears its debut.Most Read from BloombergSingapore Hands Byju's Founder His First Ever Jail TermApple to Overhaul iOS 27 Siri, AI Features: Here's a First PeekIran’s Khamenei Says No Going Back for Middle East Rocked by WarCVS Returns Zepbound to Drug Plans After Lilly Slashes Pric

Why The Story Around Ionis Pharmaceuticals (IONS) Is Shifting After Fresh Analyst Targets And Guidance
Simply Wall St.77d agoneutral
Why The Story Around Ionis Pharmaceuticals (IONS) Is Shifting After Fresh Analyst Targets And Guidance

The fair value estimate for Ionis Pharmaceuticals has shifted from US$96.73 to US$100.92, a modest reset that puts fresh numbers around the stock. This move comes during an active period of Street research, with some firms lifting targets and others trimming them, reflecting different views on how to factor pipeline milestones and revenue guidance into valuation work. As you read on, you will see what is driving these updates and how to keep track of the evolving analyst narrative around...

​Citigroup Inc. (C) Anchors Wealth Hiring in Asia
Insider Monkey77d agoneutral
​Citigroup Inc. (C) Anchors Wealth Hiring in Asia

Citigroup Inc. (NYSE:C) is one of the best 52-week high stocks to invest in, according to short sellers. On May 22, Reuters reported that Citigroup Inc. (NYSE:C) plans to direct much of its global wealth management hiring to Asia, where its private bank is expanding faster and proving more productive than in other regions. Global […]

How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation
Simply Wall St.77d agoneutral
How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation

GoodRx Holdings is back in focus after a fair value estimate was raised to US$3.18 from US$2.82, putting fresh attention on where the stock might fit in your watchlist. Some analysts have moved price targets toward US$4 while others have pulled them down into the US$2 to US$3 range, reflecting very different reads on recent guidance and the business mix. Keep reading to see what is driving that split view and how you can follow the evolving narrative around GoodRx. Analyst Price Targets don't...

Citi sets bold Pershing Square stock price target for 2026
TheStreet78d agoneutral
Citi sets bold Pershing Square stock price target for 2026

Bill Ackman finally took the keys to Pershing Square public in April, and Wall Street is now beginning to weigh in on what that company is actually worth. Citi was the first major bank to argue it could be worth a lot more than the market currently thinks. On Tuesday, May 26, the firm initiated ...

How The Ciena (CIEN) Narrative Is Evolving With AI Data Center Demand And Valuation Debate
Simply Wall St.78d agoneutral
How The Ciena (CIEN) Narrative Is Evolving With AI Data Center Demand And Valuation Debate

The updated analyst fair value estimate for Ciena has shifted from US$378.11 to US$452.12, signaling a reset in what some models suggest the stock could be worth. This change sits alongside research that highlights stronger expectations around optical networking demand tied to data center and AI infrastructure spending, while also reflecting debate over how much of that story is already in the price. As you read on, you will see how this evolving narrative is taking shape and what to watch...

Ellison Privately Vows to Keep Enlarged Paramount’s Debt in Line
Bloomberg78d agoneutral
Ellison Privately Vows to Keep Enlarged Paramount’s Debt in Line

(Bloomberg) -- It began as a concession in private conversations to assuage wary credit analysts looking at Paramount Skydance Corp.’s blockbuster takeover of Warner Bros. Discovery Inc.: a verbal pledge by the Ellison family to do whatever it takes to slash debt at the combined company.Most Read from BloombergIran’s Khamenei Says No Going Back for Middle East Rocked by WarSingapore Hands Byju's Founder His First Ever Jail TermPutin Signs Law on Use of Army to Aid Russians Detained AbroadRussia

Bloomberg78d agoneutral
Warner Bros. Tightens $15 Billion Loan Price in Hot Debt Market

(Bloomberg) -- Warner Bros. Discovery Inc. tightened pricing on its loan offering on Wednesday, a day after upsizing the deal to around $15 billion, as investor appetite for corporate credit allows borrowers to set favorable terms.Most Read from BloombergIran’s Khamenei Says No Going Back for Middle East Rocked by WarSingapore Hands Byju's Founder His First Ever Jail TermPutin Signs Law on Use of Army to Aid Russians Detained AbroadRussia Tells US to Evacuate Its Diplomats and Citizens From Kyiv